Clarivate Plc

Clarivate Plc engages in the provision of global information, analytics and workflow solutions. It operates through the Science and Intellectual Property segments. The Science segment is composed of the academia and government, and life science and healthcare product lines. The Intellectual Property segment includes the patent, trademark, domain, and IP management product lines. The company was founded in 1864 and is headquartered in London, the United Kingdom.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clarivate Plc reports strong Q4 earnings, eyes growth opportunities

Clarivate Plc delivered strong financial results in Q4 2022, driven by the successful ProQuest acquisition and solid organic growth across segments. The company is focused on achieving higher organic growth, reducing leverage, and leveraging culture for success.
While facing macroeconomic challenges and pricing pressures, Clarivate Plc is confident in its strategic plans and capital structure initiatives. Opportunities lie in leveraging AI, enhancing product offerings, and capitalizing on the positive pricing environment.
Navigating challenges such as tough comps, managing inflation impact, and balancing quarterly patterns will be crucial. The company's proactive approach to growth, focus on customer value, and upcoming Investor Day position it well for future success.

Clarivate Plc reports stable Q1 performance amidst growth challenges

Clarivate Plc's Q1 2023 performance showcased stable revenue, strong margins, and strategic financial initiatives despite challenges in net income and organic growth cadence.
The company's strengths lie in market engagement, AI innovation, maintained outlook, and effective pricing strategies, positioning it for continued growth.
Challenges include earnings volatility, execution hurdles in growth projections, and longer-term segment revenue impacts, necessitating strategic planning and operational focus.
Opportunities in AI applications, cash flow utilization, revenue drivers, and segment progress offer avenues for revenue diversification, growth investments, and market expansion.

Clarivate Plc faces revenue challenges but drives growth through innovation

Clarivate Plc's Q2 performance saw challenges in key segments impacting revenue and outlook, despite operational improvements and strategic initiatives.
While facing hurdles in patent annuities and commercialization subsegment growth, the company focuses on sustainability, product innovations, and customer-centric strategies for future growth.
Detailed financial results and revised guidance reflect the company's proactive approach to address challenges and capitalize on opportunities for sustainable growth.
With a pivot around three segments and emphasis on higher-touch sales, Clarivate aims to navigate challenges, leverage opportunities, and drive revenue growth in the evolving market landscape.

Clarivate Plc reports Q3 growth, tackles challenges, eyes tech acquisitions

Clarivate Plc's Q3 performance showed growth in key segments despite challenges in IP and LS&H businesses.
Opportunities lie in technology acquisitions, analytic platforms, and direct sales to pharma companies.
Management remains optimistic about quarterly results and progress, focusing on enhancing growth strategies.

Clarivate Plc reports solid Q4 performance amidst sector challenges

Clarivate Plc's Q4 2023 performance reflects progress in key segments and a strategic focus on organic growth and operational efficiencies.
While facing challenges in the A&G segment and market conservatism, the company is leveraging strengths in Life Sciences investments and pricing strategies.
Opportunities lie in growth acceleration through new offerings, improved organic growth, and renewed optimism in the life sciences sector.

Clarivate Plc reports Q1 revenue growth, eyes segment expansion

Clarivate Plc's Q1 performance showed promising organic revenue growth and steady renewal rates, with a focus on future investments for growth.
While facing financial challenges and neutral market conditions, the company sees opportunities in segment growth and real-world data solutions.
Overall, Clarivate remains on track with full-year guidance, aiming for 1% organic growth and focusing on driving subscription business growth.

Clarivate Plc reports mixed Q2 results, focuses on growth strategies

Clarivate Plc reported mixed financial results in Q2 2024, with slight revenue growth but challenges in certain segments.
Management emphasized resilience in adjusted EPS and operating cash flow, focusing on growth plans and operational improvements.
Analysts raised concerns about project delays and segment performance, but opportunities in product innovation and revenue growth were highlighted.
The company aims to drive subscription revenue growth through upcoming product releases and investment in business.

Clarivate Plc faces revenue decline in Q3 but focuses on growth strategies

Clarivate Plc's Q3 2024 earnings call highlighted challenges in revenue decline and net loss, with a focus on repositioning and value creation. The company is implementing a Value Creation Plan to optimize its business model and drive sustainable growth. Opportunities exist in improving sales execution, product innovation, and aligning the portfolio for enhanced profitability.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clarivate Plc engages in the provision of global information, analytics, and workflow solutions. It operates through the following segments: Academia and Government (A&G), Intellectual Property (IP), and Life Sciences and Healthcare (LS&H). The A&G segment involves the provision of research and analytics, content aggregation, and workflow software solutions using artificial intelligence. The IP segment includes the maintenance, intelligence, and management solutions. The LS&H focuses on solutions for research and development, regulatory and safety, and commercialization. The company was founded in 1864 and is headquartered in London, the United Kingdom.

End-to-end IP management solution empowers IP operations team LONDON , June 1, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform the world, announced today that Mitsubishi Electric Corporation has chosen IPfolio™ from Clarivate to optimize management of its intellectual property (IP) operations. With the implementation of this solution, Mitsubishi Electric has been able to reform its IP operations by improving IP work quality and efficiency, achieving seamless communication and enhancing IP strategic activities.

Mitsubishi Electric Chooses IPfolio from Clarivate

LONDON , May 31, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced today that the Company will present at the following investor conferences in June 2023. Jonathan Gear, Chief Executive Officer, will present at the William Blair Growth Stock Conference on Tuesday, June 6, 2023 at 3:20 pm Central Time (4:20 pm Eastern Time).

Clarivate to Present at Upcoming Investor Conferences in June 2023

Informatica

Investors looking for stocks in the Internet - Software sector might want to consider either Clarivate PLC (CLVT) or Informatica Inc. (INFA). But which of these two stocks offers value investors a better bang for their buck right now?

CLVT vs. INFA: Which Stock Should Value Investors Buy Now?

Board to Resume Share Repurchases Following Progress toward Target Leverage Range LONDON , May 24, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust, today announced that, given its reduced debt profile, the Company's Board of Directors has approved the extension of its share repurchase authorization through December 31, 2024, and reduced the authorization from $1 billion to $500 million. Jonathan Gear, Chief Executive Officer of Clarivate, said, "The changes to the share repurchase program reflect our Board and management team's confidence in Clarivate's strategy, execution and commitment to allocating our significant free cash flow towards the Company's capital structure, investing for growth and returning capital to shareholders.

Clarivate Amends Share Repurchase Program as Part of Balanced Capital Allocation Plan

Partnership enables agency-wide access to OFF-X translational safety intelligence solution LONDON , May 23, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the extension of the Material Transfer Agreement (MTA) with the FDA for an additional three years. The extension will ensure continued agency-wide access to OFF-X™ by Clarivate, which provides integrated preclinical toxicity, clinical and post-marketing adverse event data, visualizations and analytics.

Food and Drug Administration (FDA) and Clarivate Extend Material Transfer Agreement for Three Additional Years

Third annual report demonstrates how Clarivate is advancing towards the United Nations SDGs in partnership with customers LONDON , May 18, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today published its third annual sustainability report. The report demonstrates how Clarivate™ is advancing in the areas of Environment, Social and Governance (ESG), especially towards the United Nations Sustainability Goals in partnership with its customers.

Clarivate Publishes Sustainability Report for 2022

Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning among key areas of investment for pharma LONDON , May 17, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its new report, Biopharma Dealmaking in 2023.  This year's report examines how pharma companies are replenishing their pipelines as many face a steep patent cliff, with particular attention to such critical emerging modalities and technologies as antibody drug conjugates, artificial intelligence (AI) and machine learning, cell therapy, bispecific antibodies and RNA therapeutics.

New Clarivate Biopharma Dealmaking Report Reveals Investment Patterns Set to Impact the Future of Medicine

Integration of Smart Intangible Asset Management into IPfolio to transform intellectual property management Clarivate to host Innovation Lab during INTA Annual Meeting in Singapore where attendees can view a demo of IPfolio and SIAM integration LONDON , May 17, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the integration of the Smart Intangible Asset Management (SIAM) solution from IPwe Inc. into IPfolio™. This integration will enable IPfolio users to access unique patent valuation metrics from SIAM, including real-time, objective financial benchmarks on a patent-by-patent and portfolio basis, alongside competitor and peer portfolio metrics.

Clarivate and IPwe to Provide Financial Valuations and Business Insights for IP Assets

New tools gather, analyze, compare, and deliver insights from more than 140 million trademark records and more than 6.2 million trademark office and court decisions LONDON , May 16, 2023 /PRNewswire/ --  Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the launch of the Clarivate Brand Landscape Analyzer and the development of the Clarivate Trademark Watch Analyzer. Together they will enable brand professionals to assess brand risk from every angle as they make trademark intelligence more actionable.

Clarivate Launches New Artificial Intelligence Tools to Enable Trademark Professionals to Assess Brand Risk from Every Angle

Clarivate PLC (NYSE:CLVT ) Q1 2023 Earnings Conference Call May 9, 2023 9:00 AM ET Company Participants Mark Donohue - Head of Investor Relations Jonathan Gear - Chief Executive Officer & Director Jonathan Collins - Executive Vice President & Chief Financial Officer Conference Call Participants George Tong - Goldman Sachs Group Thomas Roesch - William Blair Toni Kaplan - Morgan Stanley Peter Christiansen - Citigroup Seth Weber - Wells Fargo Securities Adam Parrington - Stifel Stephanie Moore - Jefferies Operator Good morning. Thank you for attending today's Clarivate Q1 2023 Earnings Conference Call.

Clarivate PLC (CLVT) Q1 2023 Earnings Call Transcript

Clarivate PLC (CLVT) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.21 per share a year ago.

Clarivate PLC (CLVT) Q1 Earnings and Revenues Top Estimates

— Reaffirmed 2023 Outlook — LONDON , May 9, 2023 /PRNewswire/ -- Clarivate Plc - (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today reported results for the first quarter ended March 31, 2023. First  Quarter 2023 Financial Highlights Revenues of $629.1 million decreased 5.0%, and 3.1% at constant currency(1), driven primarily by the divestiture of MarkMonitor in October 2022, for which there were no comparable amounts in the current year period and year-over-year strengthening of the US dollar Organic revenues(1) decreased 0.2% as an increase in subscription revenues of 3.1% was partially offset by a decline in re-occurring revenues of 1.7% and transactional and other revenues of 8.3% Net income attributable to ordinary shares of $24.7 million decreased $26.1 million driven by the mark-to-market gain on financial instruments in the prior year quarter and an increase in interest costs, which was partially offset by a tax benefit in the current year quarter; Net income per diluted share of $0.04 increased by $0.10 Adjusted Net Income(1) of $130.9 million decreased 15.6%; Adjusted Income per diluted share(1) of $0.18 decreased 14.3% or $0.03 Adjusted EBITDA(1) of $252.7 million decreased 3.7% driven by the divestiture of MarkMonitor, partially offset by cost savings from integration programs; Adjusted EBITDA Margin(1) of 40.2% increased 60 basis points Net cash provided by operating activities increased $160.1 million to $227.5 million; Free cash flow(1) increased $142.2 million to $168.2 million, allowing for continued deleveraging through further debt reduction "Clarivate delivered results in line with our expectations for the first quarter including improved subscription revenue and strong cash flow," said Jonathan Gear, Chief Executive Officer.

Clarivate Reports First Quarter 2023 Results

Impactive's latest engagement with Clarivate shows how activists can seek potential in fallen SPAC stocks.

Impactive takes a stake in Clarivate and sets the tone for activism in the post-SPAC world

Report explores how developers are addressing challenges to market approvals and payment LONDON , May 2, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced the release of its new report, Making gene therapy work for patients, payers, regulators and developers: Five key trends in gene therapy approvals and access . The report explores the challenges and triumphs of gene therapy, with an eye on how developers are addressing risk and the need for multiple modalities and how payers are exploring alternative pay methods.

New Clarivate Report Identifies Trends in Gene Therapy Poised to Impact Patients, Payers, Regulators and Developers

Institute for Scientific Information prompts the U.S. to address shrinking domestic research capacity or risk its position as a leading science and technology power LONDON , April 27, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released an in-depth report from the Institute for Scientific Information (ISI)™ which examines the impact of globalization on United States research. The report emphasizes the importance of continued investment and collaboration to maintain the country's position as a leading science and technology power.

Clarivate Report on U.S. Research Emphasizes Need for Continued International Collaboration and Domestic Regional Investment

Concludes the appointments for business leaders of its three market segments LONDON , April 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that it has appointed Henry Levy as President, Life Sciences & Healthcare, effective May 1, 2023. Henry joins from Veeva Systems, a global leader in cloud software for the life sciences industry, where he most recently served as President, Global R&D and Quality, with responsibility for driving sales across the segment.

Clarivate Appoints Henry Levy as President, Life Sciences & Healthcare

LONDON , April 20, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced today it will report its financial results for the first quarter 2023 before the market opens on Tuesday, May 9. The press release and earnings supplement, with accompanying financial information, will be posted on the Clarivate investor website at https://ir.clarivate.com.

Clarivate to Report First Quarter 2023 Results on May 9, 2023

Appointing the second of three business leaders for its newly created market segments LONDON , April 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Bar Veinstein will join the company as President, Academia & Government, effective April 24, 2023. Bar joins from Taranis, an AI-powered crop intelligence provider, where he was Chief Executive Officer focusing on driving business growth, improving customer satisfaction and accelerating the company's artificial intelligence (AI) strategy.

Clarivate Names Bar Veinstein as President, Academia & Government

Clarivate has plummeted over 70% from its all-time high. The business has been messy but the new management team is now cleaning things up and the fundamentals remain solid.

Clarivate: A Great Recovery Play

Clarivate has a strong business model with high barriers to entry, including high pricing power and excellent top-line visibility due to its recurring revenue model and high customer retention rates. CLVT has set new medium-term financial goals focused on accelerating organic revenue growth through investments in content and technology, with a target of growing organic revenue by around 6%.

Clarivate: Organic Growth To Drive EBITDA Expansion

The CLVT business is widely adopted in the industry and has proven to be enduring and difficult to replace. CLVT should be relatively recession-proof given its mission-critical solutions and the customer base.

Clarivate: Challenges To Deliver High Growth

Centessa Pharmaceuticals PLC

Naming the first of three business leaders for its newly created market segments and nominating new Independent Director to its Board LONDON , March 23, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Gordon Samson, currently Chief Product Officer, has been appointed President of its Intellectual Property (IP) market segment, effective April 1. The Company also announced that it has nominated Dr. Saurabh Saha to stand for election as a director at its 2023 Annual General Meeting of shareholders on May 4, 2023.

Clarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent Director

LONDON , March 13, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the BofA Securities 2023 Information & Business Services Conference on Thursday, March 16, 2023 at 9:45 am Eastern Time. The live webcast can be accessed at https://bofa.veracast.com/webcasts/bofa/infoservices2023/idso9130.cfm and will be available for replay.

Clarivate to Present at the BofA Securities 2023 Information & Business Services Conference on March 16

Clarivate PLC (NYSE:CLVT ) Q4 2022 Earnings Conference Call March 1, 2023 9:00 AM ET Company Participants Mark Donohue - Head, IR Jonathan Gear - CEO & Director Jonathan Collins - EVP & CFO Conference Call Participants George Tong - Goldman Sachs Group Toni Kaplan - Morgan Stanley Seth Weber - Wells Fargo Securities John Mazzoni - RBC Capital Markets Stephanie Moore - Jefferies Adam Parrington - Stifel, Nicolaus & Company Peter Christiansen - Citigroup Operator Hello, and welcome to today's Clarivate Q4 and Full Year Earnings Conference Call. My name is Bailey, and I'll be the moderator for today's call.

Clarivate PLC (CLVT) Q4 2022 Earnings Call Transcript

Clarivate PLC (CLVT) delivered earnings and revenue surprises of 29.41% and 3.67%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

News for Clarivate Plc Stock (CLVT)